TARS Rule 144: Proposed sale of 390 shares

TARS reported a Rule 144 notice for the proposed sale of 390 shares of Common Stock tied to a restricted stock vesting on 03/18/2026.

Accepted by SEC EDGAR 03/19/2026 - 04:14 PM EDT Learn about SEC filing dates

Rhea-AI Filing Summary

TARS reported a Rule 144 notice for the proposed sale of 390 shares of Common Stock tied to a restricted stock vesting on 03/18/2026. The filing lists prior short-term transactions by Elizabeth Yeu-Lin: 375 shares on 03/17/2026 and 379 shares on 03/18/2026.

The filing identifies Fidelity Brokerage Services LLC as the broker and labels the 390-share entry as compensation-related (restricted stock vesting). This notice is an administrative disclosure of an intended resale under Rule 144.

Insights

Insider Transactions Analyst

Rule 144 filing notifies market of an intended resale following vesting.

The filing records a proposed sale of 390 shares of common stock on 03/18/2026 arising from a restricted stock vesting event, with Fidelity Brokerage Services LLC named as the broker-dealer. Two recent transactions by Elizabeth Yeu-Lin (375 and 379 shares) are listed as sales on adjacent dates.

These entries are administrative disclosures; the economic impact depends on execution and price. Subsequent filings will show whether the sales were completed and the actual proceeds.

FAQ

AI-generated questions and answers. How Rhea-AI works. Not financial advice.

What does the TARS Form 144 disclose about the 03/18/2026 transaction?

The Form 144 discloses a proposed sale of 390 shares of Common Stock tied to a restricted stock vesting on 03/18/2026. It lists Fidelity Brokerage Services LLC as the broker and classifies the entry as compensation-related.

Who is the seller named in the TARS Form 144 filing?

The filing identifies Elizabeth Yeu-Lin as the reporting person for recent transactions. It shows prior sales of 375 shares on 03/17/2026 and 379 shares on 03/18/2026, and the proposed 390-share entry tied to vesting.

Does the Form 144 confirm that the 390 shares were sold for TARS?

The Form 144 is a notice of intended resale under Rule 144 and does not itself confirm completion. It reports a proposed sale of 390 shares on 03/18/2026 tied to vesting; execution and proceeds would appear in subsequent transaction filings.

What role does Fidelity Brokerage Services LLC play in the TARS filing?

Fidelity Brokerage Services LLC is named as the broker-dealer associated with the transaction entry for 390 shares. The filing lists the broker's address and connects the entry to trades reported on or about 03/18/2026.

AI-generated analysis. How Rhea-AI works. Not financial advice.

See more from StockTitan in Google Search and AI answers. Adds StockTitan as a preferred source · opens Google

Add on Google Not now

Form 144 Filer Information	UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 Form 144 NOTICE OF PROPOSED SALE OF SECURITIES PURSUANT TO RULE 144 UNDER THE SECURITIES ACT OF 1933
FORM 144

144: Filer Information

Filer CIK	0001842190
Filer CCC	XXXXXXXX
Is this a LIVE or TEST Filing?	LIVE TEST
Submission Contact Information
Name
Phone
E-Mail Address

144: Issuer Information

Name of Issuer	Tarsus Pharmaceuticals, Inc.
SEC File Number	001-39614
Address of Issuer	15440 LAGUNA CANYON ROAD IRVINE CALIFORNIA 92618
Phone	(949) 409-9820
Name of Person for Whose Account the Securities are To Be Sold	Lin Elizabeth Yeu
See the definition of "person" in paragraph (a) of Rule 144. Information is to be given not only as to the person for whose account the securities are to be sold but also as to all other persons included in that definition. In addition, information shall be given as to sales by all persons whose sales are required by paragraph (e) of Rule 144 to be aggregated with sales for the account of the person filing this notice.
Relationship to Issuer	Officer

144: Securities Information

Title of the Class of Securities To Be Sold	Name and Address of the Broker	Number of Shares or Other Units To Be Sold	Aggregate Market Value	Number of Shares or Other Units Outstanding	Approximate Date of Sale	Name the Securities Exchange
Common	Fidelity Brokerage Services LLC 900 Salem Street Smithfield RI 02917	390	26129.53	42557492	03/19/2026	NASDAQ

Furnish the following information with respect to the acquisition of the securities to be sold and with respect to the payment of all or any part of the purchase price or other consideration therefor:

144: Securities To Be Sold

Title of the Class	Date you Acquired	Nature of Acquisition Transaction	Name of Person from Whom Acquired	Is this a Gift?	Date Donor Acquired	Amount of Securities Acquired	Date of Payment	Nature of Payment *
Common	03/18/2026	Restricted Stock Vesting	Issuer			390	03/18/2026	Compensation

* If the securities were purchased and full payment therefor was not made in cash at the time of purchase, explain in the table or in a note thereto the nature of the consideration given. If the consideration consisted of any note or other obligation, or if payment was made in installments describe the arrangement and state when the note or other obligation was discharged in full or the last installment paid.

Furnish the following information as to all securities of the issuer sold during the past 3 months by the person for whose account the securities are to be sold.

144: Securities Sold During The Past 3 Months

Name and Address of Seller	Title of Securities Sold	Date of Sale	Amount of Securities Sold	Gross Proceeds
Elizabeth Yeu-Lin 15440 Laguna Canyon Road Suite 160 Irvine CA 92618	Common	03/17/2026	375	26030.51
Elizabeth Yeu-Lin 15440 Laguna Canyon Road Suite 160 Irvine CA 92618	Common	03/18/2026	379	26041.01

144: Remarks and Signature

Remarks	Sale includes an amount necessary to cover a tax obligation resulting from the settlement of a vested equity award distribution.
Date of Notice	03/19/2026
ATTENTION:
The person for whose account the securities to which this notice relates are to be sold hereby represents by signing this notice that he does not know any material adverse information in regard to the current and prospective operations of the Issuer of the securities to be sold which has not been publicly disclosed. If such person has adopted a written trading plan or given trading instructions to satisfy Rule 10b5-1 under the Exchange Act, by signing the form and indicating the date that the plan was adopted or the instruction given, that person makes such representation as of the plan adoption or instruction date.
Signature	/s/ Jared Cook, as a duly authorized representative of Fidelity Brokerage Services LLC, as attorney-in-fact for Elizabeth Yeu-Lin
ATTENTION: Intentional misstatements or omission of facts constitute Federal Criminal Violations (See 18 U.S.C. 1001)